[Sepsismarker--what is useful?].
Brunkhorst
F M
FM
Klinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena. frank.brunkhorst@med.uni-jena.de
D000209:Acute-Phase Proteins; D000890:Anti-Infective Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis*; D002116:Calcitonin / Q000097:blood*; D002352:Carrier Proteins / Q000097:blood*; D003937:Diagnosis, Differential; D005858:Germany / Q000453:epidemiology; D006801:Humans; D015850:Interleukin-6 / Q000097:blood*; D008562:Membrane Glycoproteins / Q000097:blood*; D011379:Prognosis; D011498:Protein Precursors / Q000097:blood*; D012307:Risk Factors; D018805:Sepsis / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D012720:Severity of Illness Index; D018746:Systemic Inflammatory Response Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D000099231:Lipopolysaccharide-Binding Protein
D000209:Acute-Phase Proteins; D000890:Anti-Infective Agents; D015415:Biomarkers; D002097:C-Reactive Protein; D002116:Calcitonin; D002352:Carrier Proteins; D015850:Interleukin-6; D008562:Membrane Glycoproteins; D011498:Protein Precursors; D000099231:Lipopolysaccharide-Binding Protein